Chapel Hill-based University of North Carolina Lineberger Comprehensive Cancer Center has been awarded up to $28 million to develop an adaptive clinical trial targeting metastatic breast cancer. The trial is part of the Advanced Research Projects Agency for Health’s Advanced Analysis for Precision Cancer Therapy program, also called ADAPT. Other ADAPT awardees and their trial […]| Becker's Hospital Review | Healthcare News & Analysis
Lisa Carey, MD, ScM, FASCO, was honored by OncLive as one of its 2025 Giants of Cancer Care for her significant contributions advancing the treatment and study of breast cancer.| UNC Lineberger
The UNC Lineberger Comprehensive Cancer Center has been awarded $28 million for a new clinical breast cancer trial.| Chapelboro.com
Dr. Lisa Carey talks about the importance of research, coordinated care and helping patients make informed choices.| The University of North Carolina at Chapel Hill